StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.67+0.09 (+14.93%)

Close on Nov 18, 2026Market cap $41.89MP/E –Yield –

Connect Biopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Connect Biopharma's revenue for the twelve months ending Jun 30, 2026 was $2.95M, up 50.3% year over year. For fiscal 2025 it was $64.00K, down 99.8% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$64.00K-99.8%
FY2024Dec 31, 2024$26.03M–
FY2023Dec 31, 2023$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.77M+5666.7%
Q1 FY2026Mar 31, 2026$169.00K–
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$16.00K-98.7%
Q2 FY2025Jun 30, 2025$48.00K-99.8%
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$698.00K–
Q3 FY2024Sep 30, 2024$1.22M–
Q2 FY2024Jun 30, 2024$24.12M–

More Connect Biopharma figures

See a number that looks wrong?